|
EP4400516A1
(en)
|
2014-12-15 |
2024-07-17 |
The Regents of the University of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
EP3234120B1
(en)
|
2014-12-15 |
2025-09-03 |
The Regents of the University of California |
Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing
|
|
CN113713091A
(zh)
|
2015-02-06 |
2021-11-30 |
新加坡国立大学 |
工程免疫细胞及其用途和生产方法
|
|
US20220348633A1
(en)
*
|
2015-06-25 |
2022-11-03 |
Icell Gene Therapeutics Llc |
COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF
|
|
TWI833684B
(zh)
*
|
2015-06-25 |
2024-03-01 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體（ｃａｒ）、組合物及其使用方法
|
|
US20220241327A1
(en)
*
|
2015-06-25 |
2022-08-04 |
Icell Gene Therapeutics Llc |
Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof
|
|
JP7115982B2
(ja)
|
2015-10-30 |
2022-08-09 |
アレタ・バイオセラピューティクス・インコーポレイテッド |
癌の治療のための組成物及び方法
|
|
KR20180083868A
(ko)
|
2015-10-30 |
2018-07-23 |
알레타 바이오쎄라퓨틱스, 인크. |
종양 형질도입용 조성물 및 방법
|
|
DK3368571T5
(da)
|
2015-10-30 |
2024-09-30 |
Univ California |
Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf
|
|
US11384156B2
(en)
*
|
2016-07-25 |
2022-07-12 |
The Nemours Foundation |
Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treating IgE-mediated allergic diseases
|
|
NZ750256A
(en)
|
2016-08-03 |
2026-02-27 |
Dipersio John F |
Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
|
|
JP2019530440A
(ja)
|
2016-09-02 |
2019-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インターロイキン６受容体α結合単鎖可変断片を含む方法および組成物
|
|
JP2019535262A
(ja)
*
|
2016-11-11 |
2019-12-12 |
オートラス リミテッド |
キメラ抗原受容体
|
|
WO2018124766A2
(ko)
|
2016-12-28 |
2018-07-05 |
주식회사 녹십자랩셀 |
키메라 항원 수용체 및 이를 발현하는 자연 살해 세포
|
|
US12473343B2
(en)
|
2017-01-10 |
2025-11-18 |
The General Hospital Corporation |
Targeted t cells with cytotoxicity toward immunosuppressive cells
|
|
WO2018132513A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
T cells experessing a chimeric antigen receptor
|
|
SG11201907870VA
(en)
|
2017-02-28 |
2019-09-27 |
Vor Biopharma Inc |
Compositions and methods for inhibition of lineage specific proteins
|
|
EP4317422A3
(en)
|
2017-04-13 |
2024-05-01 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
CN110520524A
(zh)
*
|
2017-04-14 |
2019-11-29 |
综合医院公司 |
靶向肿瘤微环境的嵌合抗原受体t细胞
|
|
WO2018195339A1
(en)
*
|
2017-04-19 |
2018-10-25 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
MX2019013514A
(es)
|
2017-05-12 |
2020-01-20 |
Crispr Therapeutics Ag |
Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
|
|
CA3287539A1
(en)
|
2017-06-21 |
2026-03-02 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
|
|
US20210017247A1
(en)
|
2017-07-03 |
2021-01-21 |
Torque Therapeutics, Inc. |
Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof
|
|
US10442867B2
(en)
|
2017-07-31 |
2019-10-15 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
|
|
US20190038733A1
(en)
|
2017-08-10 |
2019-02-07 |
National University Of Singapore |
T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof
|
|
US11905528B2
(en)
*
|
2017-10-12 |
2024-02-20 |
Icell Gene Therapeutics Inc. |
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof
|
|
US20210198359A1
(en)
|
2017-10-25 |
2021-07-01 |
Actinium Pharmaceuticals, Inc. |
Anti-cd45-based lymphodepletion methods and uses thereof in conjction with act-based cancer therapies
|
|
JP7447006B2
(ja)
|
2017-11-01 |
2024-03-11 |
ジュノー セラピューティクス インコーポレイテッド |
Ｂ細胞成熟抗原（ｂｃｍａ）に特異的なキメラ抗原受容体
|
|
AU2018358067A1
(en)
|
2017-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for B-cell maturation antigen
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
US12116417B2
(en)
|
2017-11-14 |
2024-10-15 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
KR20190065234A
(ko)
*
|
2017-11-30 |
2019-06-11 |
그리폴스 다이어그노스틱 솔루션즈 인크. |
면역 관문 억제제인 pd-1 및 pd-l1에 대한 항체 치료를 모니터링하기 위한 면역분석 및 조작된 단백질
|
|
CA3087476A1
(en)
*
|
2018-01-10 |
2019-07-18 |
The General Hospital Corporation |
Immune cells expressing a chimeric antigen receptor
|
|
CN108314738B
(zh)
*
|
2018-01-29 |
2020-09-08 |
山东兴瑞生物科技有限公司 |
一种共表达细胞因子il-21的双特异性嵌合抗原受体、质粒、cik细胞及mm病应用
|
|
AU2019219454A1
(en)
|
2018-02-09 |
2020-08-27 |
National University Of Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
WO2019160956A1
(en)
*
|
2018-02-13 |
2019-08-22 |
Novartis Ag |
Chimeric antigen receptor therapy in combination with il-15r and il15
|
|
CA3091143A1
(en)
*
|
2018-02-15 |
2019-08-22 |
Memorial Sloan-Kettering Cancer Center |
Foxp3 targeting agent compositions and methods of use for adoptive cell therapy
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
KR102867256B1
(ko)
*
|
2018-03-15 |
2025-10-01 |
펀다멘탈 솔류션스 코포레이션 |
프로그램 가능한 면역세포 수용체 복합체 시스템
|
|
TW202003011A
(zh)
|
2018-03-26 |
2020-01-16 |
美商艾爾特生物科技責任有限公司 |
抗ＰＤＬ１、ＩＬ－１５及ＴＧＦ－β受體組合分子
|
|
CN112055717B
(zh)
|
2018-04-02 |
2024-04-26 |
新加坡国立大学 |
用在免疫细胞中表达的膜结合抗细胞因子非信号传导粘合剂中和人细胞因子
|
|
US20210145881A1
(en)
*
|
2018-04-09 |
2021-05-20 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating graft-versus-host disease
|
|
TWI784324B
(zh)
*
|
2018-04-12 |
2022-11-21 |
美商凱特製藥公司 |
利用腫瘤微環境之特性之嵌合受體t細胞治療
|
|
EP3561053A1
(en)
*
|
2018-04-26 |
2019-10-30 |
Baylor College of Medicine |
Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy
|
|
EP3784256A4
(en)
*
|
2018-04-27 |
2022-06-29 |
Baylor College of Medicine |
Car t cells with one or more interleukins
|
|
US12473342B2
(en)
|
2018-04-27 |
2025-11-18 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosis
|
|
CN110468105B
(zh)
*
|
2018-05-09 |
2024-03-22 |
恺兴生命科技(上海)有限公司 |
表达il-18r结合蛋白的免疫效应细胞
|
|
US12227763B2
(en)
|
2018-05-11 |
2025-02-18 |
Crispr Therapeutics Ag |
Methods and compositions for treating cancer
|
|
US20210230289A1
(en)
*
|
2018-06-12 |
2021-07-29 |
The Regents Of The University Of California |
Single-chain bispecific chimeric antigen receptors for the treatment of cancer
|
|
JP2021527409A
(ja)
|
2018-06-14 |
2021-10-14 |
ブルーバード バイオ， インコーポレイテッド |
Ｃｄ７９ａキメラ抗原受容体
|
|
WO2019246593A2
(en)
*
|
2018-06-22 |
2019-12-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders
|
|
US11951131B2
(en)
|
2018-07-03 |
2024-04-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-SLAMF7 chimeric antigen receptors
|
|
CN108864307A
(zh)
*
|
2018-07-23 |
2018-11-23 |
北京多赢时代科技有限公司 |
信号肽优化靶向cd19的嵌合抗原受体、表达该嵌合抗原受体的t细胞及制备方法和应用
|
|
US20210079111A1
(en)
*
|
2018-08-04 |
2021-03-18 |
AbCyte Therapeutics Inc. |
Cd19-cd20 bispecific and dual passway car-t and methods for use thereof
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
CA3110837A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma Inc. |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
BR112021003640A2
(pt)
*
|
2018-08-31 |
2021-05-18 |
Noile-Immune Biotech, Inc. |
célula t, medicamento, vetor de expressão, e, métodos para produzir uma célula de t car e para tratar câncer
|
|
EP3847197A1
(en)
*
|
2018-09-05 |
2021-07-14 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
|
CN110950965B
(zh)
*
|
2018-09-26 |
2021-10-15 |
重庆精准生物技术有限公司 |
抗人cd123的嵌合抗原受体及其应用
|
|
WO2020061796A1
(en)
*
|
2018-09-26 |
2020-04-02 |
Hrain Biotechnology Co., Ltd. |
Bcma-and-cd19-targeting chimeric antigen receptor and uses thereof
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
WO2020077356A1
(en)
*
|
2018-10-12 |
2020-04-16 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOF
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
SG11202103317XA
(en)
*
|
2018-10-17 |
2021-05-28 |
Senti Biosciences Inc |
Combinatorial cancer immunotherapy
|
|
US12264189B2
(en)
|
2018-10-31 |
2025-04-01 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
WO2020092736A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
KR20210113169A
(ko)
|
2018-11-01 |
2021-09-15 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Β세포 성숙 항원에 특이적인 키메라 항원 수용체를 이용한 치료 방법
|
|
SG11202104524YA
(en)
|
2018-11-01 |
2021-05-28 |
Gracell Biotechnologies Shanghai Co Ltd |
Compositions and methods for t cell engineering
|
|
MA54079A
(fr)
*
|
2018-11-01 |
2021-09-08 |
Juno Therapeutics Inc |
Récepteurs antigéniques chimériques spécifiques du gprc5d (élément d du groupe 5 de classe c des récepteurs couplés à la protéine g)
|
|
US12590148B2
(en)
|
2018-11-26 |
2026-03-31 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
US20200222462A1
(en)
|
2018-11-30 |
2020-07-16 |
Mustang Bio, Inc. |
Methods of treatment using decitabine and a cd123-targeted therapy
|
|
KR102840400B1
(ko)
*
|
2018-12-12 |
2025-08-04 |
카이트 파마 인코포레이티드 |
키메라 항원 수용체 및 car-t 세포 및 사용 방법
|
|
US12600760B2
(en)
|
2018-12-13 |
2026-04-14 |
The General Hospital Corporation |
Chimeric antigen receptors targeting CD79B and CD19
|
|
CN113260703A
(zh)
|
2018-12-24 |
2021-08-13 |
黄海东 |
突变的人2Ig-B7-H3蛋白编码基因、重组载体、包含其的宿主细胞、药物组合物及其应用
|
|
EP3908613A4
(en)
*
|
2019-01-07 |
2022-10-19 |
Celluris Participações Ltda. |
BISPECIFIC IN-TANDEM RECEPTOR CAR AND METHODS FOR MODULATION OF THE TUMOR MICROAREA
|
|
CA3128518A1
(en)
*
|
2019-02-01 |
2020-08-06 |
Actinium Pharmaceuticals, Inc. |
Molecules and their derivatives directed against cd45
|
|
AU2020232691B2
(en)
*
|
2019-03-05 |
2023-06-29 |
Nkarta, Inc. |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
WO2020197318A1
(ko)
|
2019-03-28 |
2020-10-01 |
한국생명공학연구원 |
Car 유전자가 도입된 nk 세포의 제조방법 및 그의 용도
|
|
EP3952886A1
(en)
*
|
2019-04-10 |
2022-02-16 |
Elevatebio Technologies, Inc |
Flt3-specific chimeric antigen receptors and methods of using the same
|
|
CN110055281B
(zh)
*
|
2019-04-25 |
2020-09-01 |
山东大学第二医院 |
一种用于制备car-t的慢病毒载体及其构建方法和应用
|
|
EP3962527A4
(en)
|
2019-04-30 |
2023-11-01 |
Senti Biosciences, Inc. |
CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
|
|
US20220249558A1
(en)
|
2019-04-30 |
2022-08-11 |
Crispr Therapeutics Ag |
Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19
|
|
AU2020265741A1
(en)
*
|
2019-05-01 |
2021-11-25 |
Editas Medicine, Inc. |
Cells expressing a recombinant receptor from a modified TGFBR2 Locus, related polynucleotides and methods
|
|
EP3747904A1
(en)
*
|
2019-06-03 |
2020-12-09 |
Universität Regensburg |
Cd25-specific chimeric antigen receptors and their uses
|
|
AU2020286471B2
(en)
*
|
2019-06-07 |
2025-07-31 |
The Trustees Of The University Of Pennsylvania |
Dual CAR expressing T cells individually linked to CD28 and 4-1BB
|
|
US20220280567A1
(en)
*
|
2019-06-14 |
2022-09-08 |
2Seventy Bio, Inc. |
Compositions and methods for treating cancer
|
|
WO2020263484A1
(en)
*
|
2019-06-28 |
2020-12-30 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating neuromyelitis optica spectrum diseases
|
|
CN112204135B
(zh)
*
|
2019-07-06 |
2026-03-06 |
苏州克睿基因生物科技有限公司 |
一种表达cd3抗体受体复合物的免疫细胞及其用途
|
|
EP3997129B1
(en)
*
|
2019-07-11 |
2025-11-26 |
Valkyr, Inc. |
System and methods relating to chimeric autoantibody receptors
|
|
WO2021009694A1
(en)
*
|
2019-07-17 |
2021-01-21 |
National University Of Singapore |
Functional binders synthesized and secreted by immune cells
|
|
CN110452294B
(zh)
|
2019-08-06 |
2020-08-07 |
复旦大学 |
五种铰链区及其嵌合抗原受体和免疫细胞
|
|
WO2021041936A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Montefiore Medical Center |
Cd25 chimeric antigen receptors and uses thereof
|
|
WO2021057906A1
(zh)
*
|
2019-09-25 |
2021-04-01 |
科济生物医药（上海）有限公司 |
表达il-15的免疫效应细胞
|
|
GB2607716B
(en)
*
|
2019-10-01 |
2024-10-30 |
Univ Case Western Reserve |
Targeting B cell activating factor receptor (BAFF-R) using ligand-based chimeric antigen receptor (CAR)-T cells
|
|
EP4041297A4
(en)
|
2019-10-11 |
2024-02-28 |
The Trustees of The University of Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING CD13 AND TIM-3 WITH CAR-T CELLS FOR TREATING ACUTE MYELOID LEUKEMIA
|
|
TWI717880B
(zh)
|
2019-10-24 |
2021-02-01 |
中國醫藥大學附設醫院 |
Hla-g特異性嵌合抗原受體、核酸、hla-g特異性嵌合抗原受體表達質體、表達hla-g特異性嵌合抗原受體細胞、其用途以及用於治療癌症之醫藥組合物
|
|
CN115925976A
(zh)
*
|
2019-11-21 |
2023-04-07 |
博生吉医药科技(苏州)有限公司 |
Cd7-car-t细胞及其制备和应用
|
|
CA3160759A1
(en)
*
|
2019-12-05 |
2021-06-10 |
Vycellix, Inc. |
Modulators of the immune escape mechanism for universal cell therapy
|
|
KR20220122656A
(ko)
|
2019-12-06 |
2022-09-02 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Ｇｐｒｃ5ｄ-표적화 결합 도메인에 대한 항-이디오타입 항체 및 관련 조성물 및 방법
|
|
CN114761038A
(zh)
*
|
2020-02-24 |
2022-07-15 |
凯斯西储大学 |
使用基于配体的嵌合抗原受体(car)-t细胞靶向b细胞激活因子受体(baff-r)
|
|
KR20220147109A
(ko)
*
|
2020-02-27 |
2022-11-02 |
노파르티스 아게 |
키메라 항원 수용체 발현 세포의 제조 방법
|
|
WO2021207171A1
(en)
*
|
2020-04-06 |
2021-10-14 |
St. Jude Children's Research Hospital, Inc. |
B7-h3 chimeric antigen receptors
|
|
CN111411085A
(zh)
*
|
2020-04-10 |
2020-07-14 |
格源致善(上海)生物科技有限公司 |
一种嵌合抗原受体t细胞及其应用
|
|
CN113527507A
(zh)
*
|
2020-04-16 |
2021-10-22 |
上海赛比曼生物科技有限公司 |
靶向cd22的嵌合抗原受体及其制法和应用
|
|
CN115777017A
(zh)
*
|
2020-05-06 |
2023-03-10 |
亘喜生物科技（上海）有限公司 |
用于t细胞工程改造的组合物及方法
|
|
JP7748393B2
(ja)
|
2020-05-08 |
2025-10-02 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
Ａｐｒｉｌおよびｂａｆｆ阻害免疫調節タンパク質、ならびにその使用方法
|
|
WO2022040577A1
(en)
*
|
2020-08-20 |
2022-02-24 |
City Of Hope |
Compositions and uses of cd45 targeted chimeric antigen receptor modified t cells
|
|
JP7849891B2
(ja)
*
|
2020-08-24 |
2026-04-22 |
シャリテ－ウニベルジテーツメディツィン ベルリン |
Ｃｅａを認識するキメラ抗原受容体（ｃａｒ）発現細胞
|
|
WO2022052913A1
(en)
*
|
2020-09-08 |
2022-03-17 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
WO2022061837A1
(en)
*
|
2020-09-27 |
2022-03-31 |
Jiangsu Cell Tech Medical Research Institute Co., Ltd. |
Fibronectin extra domain b (edb) -specific car-t for cancer
|
|
CN116783283A
(zh)
*
|
2020-11-13 |
2023-09-19 |
Gpb科学有限公司 |
产生具有增加的核酸摄取的细胞群体的方法
|
|
US11591381B2
(en)
|
2020-11-30 |
2023-02-28 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
CN116981685A
(zh)
*
|
2020-12-03 |
2023-10-31 |
世纪治疗股份有限公司 |
基因工程化细胞及其用途
|
|
AU2021392032A1
(en)
|
2020-12-03 |
2023-06-22 |
Century Therapeutics, Inc. |
Genetically engineered cells and uses thereof
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
CN115786271B
(zh)
*
|
2021-01-12 |
2025-07-22 |
上海雅科生物科技有限公司 |
靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用
|
|
CN112778427B
(zh)
*
|
2021-01-29 |
2022-03-15 |
武汉思安医疗技术有限公司 |
双特异性cs1-bcma car-t细胞及其应用
|
|
US20220267423A1
(en)
*
|
2021-02-22 |
2022-08-25 |
IgGenix, Inc. |
Ige antibodies cross-reactive to allergens and tumor antigens
|
|
CN112698037B
(zh)
*
|
2021-03-25 |
2021-06-25 |
北京积水潭医院 |
一种检测多发性骨髓瘤治疗效果的抗体组合物及其试剂盒和应用
|
|
WO2022234976A1
(ko)
*
|
2021-05-04 |
2022-11-10 |
주식회사 이뮤노로지컬디자이닝랩 |
키메릭 항원 수용체(car)를 포함하는 형질전환된 항원 특이적 전문적 항원표출세포 및 이의 용도
|
|
KR102671411B1
(ko)
*
|
2021-05-11 |
2024-06-04 |
진화섭 |
Baff 세포외 도메인을 포함하는 키메릭 항원 수용체 및 이의 용도
|
|
CN115340610A
(zh)
*
|
2021-05-12 |
2022-11-15 |
珠海市丽珠单抗生物技术有限公司 |
双特异性car t细胞及其应用
|
|
CN113501884B
(zh)
*
|
2021-06-30 |
2022-03-22 |
徐州医科大学 |
靶向B7H3的全人源嵌合抗原受体、iNKT细胞及其用途
|
|
CN113549158B
(zh)
*
|
2021-07-19 |
2022-10-21 |
广州百暨基因科技有限公司 |
包含突变型il15以及嵌合抗原受体的融合蛋白
|
|
WO2023009989A1
(en)
*
|
2021-07-26 |
2023-02-02 |
Kite Pharma, Inc. |
Split chimeric antigen receptors and methods of use
|
|
US20250222102A1
(en)
*
|
2021-08-24 |
2025-07-10 |
City Of Hope |
Nk cells expressing il-15 and checkpoint inhibitors for the treatment of cancer
|
|
KR20230032557A
(ko)
*
|
2021-08-31 |
2023-03-07 |
주식회사 이뮤노로지컬디자이닝랩 |
Baff 세포외 도메인을 포함하는 재조합 단백질 및 이를 유효성분으로 포함하는 암의 치료용 약학적 조성물
|
|
JP2024536791A
(ja)
*
|
2021-09-16 |
2024-10-08 |
ジーティー バイオファーマ インコーポレイテッド |
Ｂ７－ｈ３標的指向融合タンパク質及びそれを使用する方法
|
|
US20250041339A1
(en)
*
|
2021-11-19 |
2025-02-06 |
The Trustees Of The University Of Pennsylvania |
Engineered Pan-Leukocyte Antigen CD45 to Facilityate CAR T Cell Therapy
|
|
US20230210900A1
(en)
*
|
2022-01-04 |
2023-07-06 |
Kyverna Therapeutics, Inc. |
Methods for treating autoimmune diseases
|
|
EP4272754A1
(en)
|
2022-05-04 |
2023-11-08 |
Universitätsklinikum Hamburg-Eppendorf |
Method for producing cells expressing a chimeric antigen receptor (car)
|
|
WO2023217796A1
(en)
*
|
2022-05-10 |
2023-11-16 |
Miltenyi Biotec B.V. & Co. KG |
Compositions comprising il-15, il-15 receptor alpha and the intracellular signaling domain of cd2 for immune cell therapy
|
|
WO2024026455A2
(en)
*
|
2022-07-29 |
2024-02-01 |
Shoreline Biosciences, Inc. |
Methods and compositions for generating chimeric antigen receptor-monocytes/macrophages
|
|
EP4487868A1
(en)
|
2023-07-06 |
2025-01-08 |
Universitätsklinikum Hamburg-Eppendorf |
Modified nk cell expressing a chimeric antigen receptor
|
|
WO2025059162A1
(en)
|
2023-09-11 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Car-engager containing il-2 variants to enhance the functionality of car t cells
|
|
WO2025072372A1
(en)
*
|
2023-09-26 |
2025-04-03 |
The General Hospital Corporation |
Car-t cells expressing vegf binding proteins
|
|
CN117050195B
(zh)
*
|
2023-10-13 |
2023-12-19 |
旭和（天津）医药科技有限公司 |
一种靶向baffr嵌合抗原受体、car-t细胞和应用
|
|
WO2025264723A1
(en)
*
|
2024-06-18 |
2025-12-26 |
The University Of Chicago |
Co-expressed chimeric antigen receptors for cancer treatment
|